Surgery for tumors near the sensorimotor cortex poses risks to both sensory and motor pathways. While the sensory pathways may be monitored successfully with somatosensory evoked potentials (SEP), the motor pathways pose different challenges. Transcranial motor evoked potentials (tcMEP) are now routinely used for monitoring motor pathways in the spinal cord.
of these were minor, and either self-limiting or easily terminated by application of cold Ringer's solution to the cortex, the possibility remains that a significant seizure involving the upper body could pose serious risks to a patient in a head fixation system for surgery. Thus, a method for mapping that is less likely to produce such activity remains a desirable goal.
When transcranial motor-evoked potentials (tcMEP) were first introduced, there were similar concerns about the possibility of eliciting seizure activity; transcranial electrical stimulation had been used for years to intentionally induce seizures in the context of electroconvulsive therapy for treatment of severe depression. However, these fears turned out to be largely baseless. In a review of the safety of tcMEP monitoring, MacDonald 4 identified only five events of intraoperative seizures in over 15,000 cases monitored with tcMEP. Many of these were suspected to be spontaneous or possibly related to specific anesthetic agents. In any event, this incidence of 0.03 % is clearly far superior to the 24 % observed in the Yingling et al. study. 3 As a consequence, many investigators are now adapting the tcMEP technique to direct mapping of the exposed cortex, a technique we will term dcMEP (direct cortical motor-evoked potentials).
Taniguchi et al. 5 first described the principle of multi-pulse direct cortical stimulation with brief high-frequency trains. They calculated that the total charge per train was <8 μC, compared with 600-5,000 μC/train for the traditional Penfield 60 Hz technique. Subsequent clinical studies 6, 7 reported a zero incidence of seizures using the dcMEP technique, with an overall success rate of 97 % in obtaining dcMEP responses.
Subsequently, Szelényi et al. 8 compiled the data reported in several published series using each of the two techniques. The overall incidence of seizures using the dcMEP method was 5 of 421 patients (1.2 %), compared with 26 of 272 (9.5 %) for the 60 Hz method, which was a highly significant reduction. This technique is now beginning to supplant the Penfield method in most European centers, 9 but despite its advantages it has been slower to be adopted in the US, mainly owing to the lack of appropriate Food and Drug Administration (FDA) approved cortical stimulators.
A further advantage of the dcMEP technique is that, unlike prolonged 60 Hz stimulation, it does not produce any visible movements. Thus, after mapping of the cortical motor cortex, a strip electrode can be 
Cortical Motor MappingTechnique and Interpretation
The first step in mapping the sensorimotor cortex is often locating the central sulcus by the polarity reversal of the median nerve SEP.
Pyramidal cells located in the postcentral sulcus, which are oriented so that the response is negative posteriorly, and positive anteriorly, On the other hand, if the tumor is not in close proximity to the presumed precentral motor cortex (based on SEP reversal), then stimulation through the same strip electrode used for SEP recording is quite satisfactory.
Recall that to record the polarity reversal of the SEP, the electrode contacts should be oriented perpendicular to the central sulcus, so that some contacts are over precentral and others over postcentral regions.
Once the site of reversal has been determined, the electrode should be The Grass and Nicolet devices incorporate switching matrices so that electrocorticograms can be recorded from an array of electrodes, and any pair of electrodes can be selected to connect to the stimulator while the others remain connected to the EEG inputs. All of these devices have a limited range of stimulation parameters that can be selected (typically 60-100 Hz maximum), and none can be triggered by an external device, which would allow brief high frequency trains to be elicited. Grass
Instruments also markets constant current stimulus isolation units, which can be coupled to research stimulators to provide safely isolated outputs;
however, these are all marketed for research purposes only, and none have FDA clearance for clinical use in humans.
As this article goes to press, Digitimer, the manufacturer of the D-185 transcranial stimulator, is developing a new cortical stimulator. This device, the DCS2, will emulate the historic Ojemann protocol, but will also be capable of delivering triggered high frequency trains for dcMEP stimulation as described above. Prototypes of this device will be evaluated in late 2011, and FDA approval will be sought as soon as testing is complete. The availability of the DCS2 should facilitate the transition to the preferred dcMEP technique in the US. The charge delivered to the brain during each stimulus pulse is the product of intensity and duration. Since the OCS-2 pulses are 500 μs long (for each phase of the biphasic waveform), they are 10 times the duration of a 50 μs pulse. Dividing the current for the brief pulses by 10, we obtain an equivalent value of 2-10 mA per pulse, comparable to thresholds obtained with the OCS-2. Since the trains are only five pulses long (compared to 60 for a 1 s train at 60 Hz), each train using the brief high frequency technique delivers roughly an order of magnitude less charge to the brain than a single train from the OCS-2. This is presumably the reason for the much lower incidence of induced seizures.
Once mapping of the motor cortex is complete, the strip electrode is left in place to permit continuous monitoring of corticospinal tract function.
Since stimulation at near-threshold values produces no overt movements, the stimulator can be set to present repeated trains at any desired rate.
Since no signal averaging is required, stimulation at a rate of one train 
